GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (FRA:7W3) » Definitions » EV-to-Revenue

Acotec Scientific Holdings (FRA:7W3) EV-to-Revenue : 2.80 (As of Jun. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Acotec Scientific Holdings's enterprise value is €170.53 Mil. Acotec Scientific Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €60.97 Mil. Therefore, Acotec Scientific Holdings's EV-to-Revenue for today is 2.80.

The historical rank and industry rank for Acotec Scientific Holdings's EV-to-Revenue or its related term are showing as below:

FRA:7W3' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.17   Med: 5.25   Max: 24.12
Current: 2.76

During the past 5 years, the highest EV-to-Revenue of Acotec Scientific Holdings was 24.12. The lowest was -0.17. And the median was 5.25.

FRA:7W3's EV-to-Revenue is ranked better than
53.03% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.02 vs FRA:7W3: 2.76

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-22), Acotec Scientific Holdings's stock price is €0.77. Acotec Scientific Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.20. Therefore, Acotec Scientific Holdings's PS Ratio for today is 3.81.


Acotec Scientific Holdings EV-to-Revenue Historical Data

The historical data trend for Acotec Scientific Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings EV-to-Revenue Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 6.03 9.82 5.46

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only 6.03 - 9.82 - 5.46

Competitive Comparison of Acotec Scientific Holdings's EV-to-Revenue

For the Medical Devices subindustry, Acotec Scientific Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acotec Scientific Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's EV-to-Revenue falls into.



Acotec Scientific Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Acotec Scientific Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=170.530/60.966
=2.80

Acotec Scientific Holdings's current Enterprise Value is €170.53 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acotec Scientific Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €60.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acotec Scientific Holdings  (FRA:7W3) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Acotec Scientific Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.77/0.202
=3.81

Acotec Scientific Holdings's share price for today is €0.77.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acotec Scientific Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings (FRA:7W3) Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.

Acotec Scientific Holdings (FRA:7W3) Headlines

No Headlines